Published on 19 Mar 2024 on Simply Wall St. via Yahoo Finance
Key Insights
Using the 2 Stage Free Cash Flow to Equity, Standard BioTools fair value estimate is US$2.46Current share price of US$2.59 suggests Standard BioTools is potentially trading close to its fair valueWhen compared to theindustry average discount of -16%, Standard BioTools' competitors seem to be trading at a greater premium to fair value
How far off is Standard BioTools Inc. (NASDAQ:LAB) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. Our analysis will employ the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.